Clinical trials require strict adherence to protocol, extensive documentation, complete accuracy, compliance to ICH-GCP and other regulatory norms, an ethically sound patient recruitment strategy, and efficient site management.


QUICK LINKS          
CRP Course I5 Site List
Scheldule Y CDSCO Website
GCP E6 Guideline FDA Guidance


  • CDSCO issues diretion to Zonal Offices for conduction inspection of clinical trial site
  • Clinical trial industry is no killing machine: G.N. Singh - Livemint
  • Draft Guideline of FDA on Electronic Source Capturing
  • ICH makes progress on ongoing reforms and adopts Guidelines for safety reporting. Press Release - ICH Steering Committee, San Diego, California, USA, November 2012
  • DCGI initiates surprise inspection drive on CROs across India
  • Recent draft guidelines release by DCGI for public review and opinion
  • I5 Clinical Research launches FREE GCP Accreditation Test (GAT) for Clinical Research Professionals
  • I5 Clinical Research launches Clinical Research Professional (CRP) Course
  • INC Research to acquire Kendle International
  • Nautic purchase of Omnicare Clinical Research part of recent acquisition trend of mid-sized CROs


I5 is an organization formed in 2009 as a SDMO (Site Management and Development Organization) by a group of experienced Clinical and Healthcare professionals and intends to improvise the quality standards of Health care in India by improving standards of Research, Education and Treatment. I5 was set up with an innovative approach and ideas to fulfill the increasing demands of quality health care in Indian. Human research require strict adherence to research protocol, extensive documentation, complete accuracy, compliance to ICH-GCP and other regulatory norms, an ethically sound patient recruitment strategy, and efficient site management. To address these critical requirements, I5 provides site development and management services to contract research organization (CRO), Pharmaceutical, Biotechnology, Medical device industry and Clinical site through our SDMO division.

As an evolution process I5 had developed two independent divisions; a SCRO (Specialized Contract Research Organization) in 2011 to provide end to end services with respect to IITs (Investigator Initiated Trials), PMSSs (Post Market Surveillance Studies), MMSs (Medico Marketing Studies) collectively Post Market studies (PMS) to Pharmaceutical and life science companies and in 2012 a CRO (Contract Research Organization) in order to provide full-fledged service starting from designing till reporting of studies like Pilot, Pivotal, Phase and Therapeutic Equivalent studies to Pharmaceutical, Biotechnology and Medical device industry.

We design and manage effective Post Market Studies and Phase studies in association with respective key opinion leaders. We intend to educate sites, professionals and people in general who can contribute significantly in improving health care standards.

We consistently strive to be the best place for our customers and ensure that we satisfy your specific and unique needs. Go ahead and explore our details to learn how you and we can make a difference!



We aspire to be the best health care company in the eyes of our customers, community and people. We expect and demand the best we have to offer by always keeping company’s core values at the top of the mind.

We aspire to reach our goals by meeting the needs and expectations of our customers with continuous improvements in quality, efficiency, values, new services and customer satisfaction.

We aspire to raise the quality standards of Indian health care to International level and to develop and implement innovative ideas throughout India in order to provide end to end support to pharmaceutical companies in drug development. We aspire to contribute remarkably in making India known as preferred Clinical trial country not only for its patient population and cost but also for its quality data.

We aspire to known as a company who makes a difference in every human, by empowering global pharmaceuticals research project for better and faster quality research data, by improving their health and thus helping in making healthier lives.



Guided by relentless focus on our core values, we will constantly strive to implement the critical initiatives required to achieve our vision. In doing this, we will deliver operational excellence in every corner of the Company and meet or exceed our commitments to the customers we serve. All of our long-term strategies and short-term actions will be moulded by a set of core values that are shared by each and every associate. Company’s current vision is:

  1. To be among 10 percent in our business in terms of profit after tax (PAT) and return on investment (ROI).
  2. To be one of the top 3 admired companies in our industry.
  3. To contribute a portion of our PAT in improving people’s health.
  4. To be known as a company of Ethics and Quality within the industry.




  • CARE - We care for People, Customer and Employees
  • LEARN - We are dedicated to improve skills and knowledge
  • ACHIEVE - We are dedicated to achieve our goals and through aspiration, accountability and action oriented approach
  • SHARE - We share as a team. We share knowledge and encourage each other
  • SERVE - We serve the humans, we serve our customers and we serve our employees
  • INNOVATION - We innovate and introduce newer ways of services
  • QUALITY - We commit ourselves to quality
MESSAGE FROM I5 (For CR Industry)


To support the successful outcome of clinical trials for the pharmaceutical, biotechnology, and medical device industries we are and will continually strive to be the finest resource for you and to ensure that we satisfy our customer’s specific and unique needs.

As a company,

  • We present qualified, pre-screened, Principal Investigators for participation in drug research in virtually any specialty area through our SDMO division.
  • We provide access to a large patient population with diversified indications through our exclusive site of our SDMO division.
  • We design effective Post Market Studies with assistance of respective expertise and key opinion leaders through our SCRO division.
  • We provide most cost effective End to End services with respect to Clinical Trials Conduct in India through our CRO division.
  • We assure you the best quality in best rate in all our association.

In order to help your organization reduce cost and errors, and get your product to the market faster and to do future research on a marketed product, I5 Clinical research Pvt. Ltd will work with you to quickly recruit qualified Investigators for your upcoming clinical studies. Let us become your preferred functional service provider.



Home  |  Contact Us © 2011. All rights reserved. I5 Clinical Research Pvt Ltd.  Terms & Conditions  |  Privacy Policy